Detalhe da pesquisa
1.
Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer.
Oncologist
; 26(6): 465-e917, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33469991
2.
An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance).
Pharmacogenet Genomics
; 29(6): 123-131, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30889042
3.
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM).
Oncologist
; 24(7): 921-932, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30552157
4.
A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer.
BMC Cancer
; 19(1): 1032, 2019 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31675952
5.
Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer.
Br J Cancer
; 119(12): 1451-1455, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30487637
6.
A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer.
Oncologist
; 23(7): 782-790, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572245
7.
Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma.
Radiology
; 285(1): 311-318, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28787261
8.
Clinical outcomes of patients with advanced gastrointestinal stromal tumors: safety and efficacy in a worldwide treatment-use trial of sunitinib.
Cancer
; 121(9): 1405-13, 2015 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25641662
9.
Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study.
Support Care Cancer
; 23(5): 1311-9, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25341548
10.
Effects of the combination of TRC105 and bevacizumab on endothelial cell biology.
Invest New Drugs
; 32(5): 851-9, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24994097
11.
A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors.
Invest New Drugs
; 32(5): 937-45, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24916770
12.
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer.
Invest New Drugs
; 32(2): 330-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24173967
13.
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
Invest New Drugs
; 32(4): 700-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24711126
14.
The search for biomarkers to direct antiangiogenic treatment in epithelial ovarian cancer.
Gynecol Oncol
; 135(2): 349-58, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25178997
15.
Palliative treatment of metastatic colorectal cancer: what is the optimal approach?
Curr Oncol Rep
; 16(1): 363, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24293074
16.
Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study.
Pharmacoepidemiol Drug Saf
; 23(7): 726-34, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24830357
17.
Metastatic ampullary adenocarcinoma presenting as a hydrocele: a case report.
JOP
; 15(3): 266-8, 2014 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24865540
18.
Analysis of early hypertension and clinical outcome with bevacizumab: results from seven phase III studies.
Oncologist
; 18(3): 273-80, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23485622
19.
Efficacy and safety of bevacizumab in metastatic colorectal cancer: pooled analysis from seven randomized controlled trials.
Oncologist
; 18(9): 1004-12, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23881988
20.
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas.
Oncologist
; 18(3): 271-2, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23485624